Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Learn about various ways to earn cash now that can help you address urgent financial needs. Take action for better financial health.
24,501 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Workers say their benefits aren’t safety nets but leverage points used to keep them in place. This timely report expl...
AMD delivered a strong Q1 FY2026, prompting a broad uprising in analyst targets. Nine firms boosted price targets as ...
A prominent crypto trader files a lawsuit against Coinbase claiming it refused to return DAI funds stolen in a phishi...
Publishing 500 posts taught me that steady habits beat flashy efforts. This article shares investing lessons drawn fr...
AI demand is broadening from chipmakers to the hardware backbone that powers deployments, a shift that could lift inf...
NVIDIA is piloting residential micro data centers in new homes, pairing Span panels with PulteGroup builds to tap gri...
Coinbase missed earnings and then endured a multi-hour outage tied to an AWS failure, shaking investors. bulls argue ...
The Federal Trade Commission sent a formal warning to Mortgage Connect over its use of noncompete agreements, citing ...
Tensions in the Persian Gulf surged after Bahrain said 41 people were detained in a crackdown tied to Iran’s Revoluti...
Florida citrus growers face a multi-year test as disease, drought, and storms erode yields and profits. Farmers are a...
SUI surged 37% over the past seven days, powered by institutional staking inflows and a protocol upgrade that enables...